JP2023527365A5 - - Google Patents
Info
- Publication number
- JP2023527365A5 JP2023527365A5 JP2022572586A JP2022572586A JP2023527365A5 JP 2023527365 A5 JP2023527365 A5 JP 2023527365A5 JP 2022572586 A JP2022572586 A JP 2022572586A JP 2022572586 A JP2022572586 A JP 2022572586A JP 2023527365 A5 JP2023527365 A5 JP 2023527365A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- drug
- enpp1
- enpp3
- stent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030870P | 2020-05-27 | 2020-05-27 | |
| US63/030,870 | 2020-05-27 | ||
| PCT/US2021/034576 WO2021243054A1 (en) | 2020-05-27 | 2021-05-27 | Compositions and methods for inhibiting vascular smooth muscle cell proliferation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527365A JP2023527365A (ja) | 2023-06-28 |
| JP2023527365A5 true JP2023527365A5 (enExample) | 2024-06-04 |
Family
ID=78722799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572586A Pending JP2023527365A (ja) | 2020-05-27 | 2021-05-27 | 血管平滑筋細胞増殖を阻害するための組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230330307A1 (enExample) |
| EP (1) | EP4157328A4 (enExample) |
| JP (1) | JP2023527365A (enExample) |
| KR (1) | KR20230047334A (enExample) |
| CN (1) | CN116367851A (enExample) |
| AU (1) | AU2021281267A1 (enExample) |
| CA (1) | CA3180119A1 (enExample) |
| CO (1) | CO2022018016A2 (enExample) |
| IL (1) | IL298482A (enExample) |
| MX (1) | MX2022014733A (enExample) |
| TW (1) | TW202214293A (enExample) |
| WO (1) | WO2021243054A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3246841A1 (en) * | 2022-04-04 | 2023-10-12 | Biomarin Pharmaceutical Inc. | TREATMENT FOR ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY |
| CN115433776B (zh) * | 2022-09-30 | 2023-12-22 | 中国医学科学院阜外医院 | Ccn3在调控血管平滑肌细胞钙化中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101141933B (zh) * | 2004-03-10 | 2015-07-29 | 祥丰医疗有限公司 | 内皮配体结合涂覆的医疗装置 |
| US11039942B2 (en) * | 2006-06-13 | 2021-06-22 | Sino Medical Sciences Technology Inc. | Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers |
| EP3471747A1 (en) * | 2016-06-16 | 2019-04-24 | Alexion Pharmaceuticals, Inc. | Methods of treating myointimal proliferation |
| US12134790B2 (en) * | 2017-09-27 | 2024-11-05 | Inozyme Pharma, Inc. | Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1) |
| JP2021523139A (ja) * | 2018-05-08 | 2021-09-02 | イエール ユニバーシティ | 腎石症の進行を遅らせるための組成物および方法 |
| EP3844280A4 (en) * | 2018-08-31 | 2022-09-14 | Yale University | ENPP1 POLYPEPTIDES AND METHODS OF USE |
-
2021
- 2021-05-27 CA CA3180119A patent/CA3180119A1/en active Pending
- 2021-05-27 KR KR1020227045745A patent/KR20230047334A/ko active Pending
- 2021-05-27 EP EP21812363.6A patent/EP4157328A4/en not_active Withdrawn
- 2021-05-27 JP JP2022572586A patent/JP2023527365A/ja active Pending
- 2021-05-27 IL IL298482A patent/IL298482A/en unknown
- 2021-05-27 CN CN202180043445.6A patent/CN116367851A/zh active Pending
- 2021-05-27 WO PCT/US2021/034576 patent/WO2021243054A1/en not_active Ceased
- 2021-05-27 AU AU2021281267A patent/AU2021281267A1/en active Pending
- 2021-05-27 TW TW110119287A patent/TW202214293A/zh unknown
- 2021-05-27 MX MX2022014733A patent/MX2022014733A/es unknown
-
2022
- 2022-11-23 US US18/058,712 patent/US20230330307A1/en not_active Abandoned
- 2022-12-13 CO CONC2022/0018016A patent/CO2022018016A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kukielka et al. | Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. | |
| Taddei et al. | Inhibitory effect of full-length human endostatin on in vitro angiogenesis | |
| Lawrence et al. | Rapamycin suppresses experimental aortic aneurysm growth | |
| US6218372B1 (en) | Methods for treating restenosis with p21 | |
| JP3763479B2 (ja) | 生物学的に活性なＴＧＦ−β１およびＴＧＦ−β２ペプチド | |
| RU2311910C2 (ru) | Ингибирование stat-1 | |
| CN100540058C (zh) | Il-18抑制剂制备药物的用途 | |
| JP2001503755A (ja) | Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用およびデリバリー装置 | |
| JP2001520238A (ja) | 低毒性のヒトインターフェロン−αアナログ | |
| CA2259228A1 (en) | Adenoviral mediated gene transfer in adipocytes and related implants | |
| JP2002510655A (ja) | 免疫抑制剤としての間葉幹細胞によるｔ細胞応答を阻害する方法とその利用 | |
| USRE39219E1 (en) | Growth arrest homebox gene | |
| JPH0692318B2 (ja) | 不要細胞の分解あるいは阻止物質からなる治療剤 | |
| JP2023527364A5 (enExample) | ||
| Fishbein et al. | Site specific gene delivery in the cardiovascular system | |
| EP0868434A1 (fr) | Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments | |
| WO2007025166A2 (en) | Devices, compositions and methods for the protection and repair of cells and tissues | |
| CN105079780B (zh) | 一种特异结合trb3的多肽在治疗腹主动脉瘤中的应用 | |
| RU2311456C2 (ru) | Модуляция экспрессии stat-1-зависимых генов | |
| Chung et al. | Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries | |
| JP2010519234A (ja) | 治療・診断効果を有する二重特異性融合タンパク質 | |
| US20130123306A1 (en) | Inhibition of Mitogen-activated Protein Kinases in Cardiovascular Disease | |
| AU765167B2 (en) | Targeting of molecules to large vessel endothelium using EPCR | |
| Rodell et al. | Role of kinins in inflammatory responses: Prospects for drug therapy | |
| CN116406281A (zh) | 用于治疗外周动脉疾病的组合物和方法 |